Stay updated on Nivolumab Combo for Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Combo for Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedA site-wide banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check9 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the previous study record content with an error screen. As a result, the trial details, locations, and related information are no longer accessible on the page.SummaryDifference18%

- Check58 days agoChange DetectedA new funding/identifier line '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. The page revision note updated to v3.6.6, replacing v3.6.5.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a minor update to the page template or underlying CMS rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo for Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.